Skip to main content

Gentris to Provide Pharmacogenomic Services to Quintiles Japan

NEW YORK, Aug. 16 (GenomeWeb News) - Gentris will provide pharmacogenomic services to Quintiles Transnational Japan, the Research Triangle Park, NC-based company said today.


Under the agreement, Gentris will provide a number of pharmacogenomic services to Quintiles Japan, a subsidiary of pharmaceutical services provider Quintiles Transnational of Research Triangle Park, NC. These services include DNA isolation and purification, DNA banking and sample repositories, clinical genotyping, protocol development, informed consent development, and regulatory consulting services.


The two companies are already working on projects involving several Japanese pharmaceutical companies.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.